[go: up one dir, main page]

BRPI0411916A - sulfonamide-substituted imidazoquinolines - Google Patents

sulfonamide-substituted imidazoquinolines

Info

Publication number
BRPI0411916A
BRPI0411916A BRPI0411916-9A BRPI0411916A BRPI0411916A BR PI0411916 A BRPI0411916 A BR PI0411916A BR PI0411916 A BRPI0411916 A BR PI0411916A BR PI0411916 A BRPI0411916 A BR PI0411916A
Authority
BR
Brazil
Prior art keywords
sulfonamide
useful
substituted
compounds
substituted imidazoquinolines
Prior art date
Application number
BRPI0411916-9A
Other languages
Portuguese (pt)
Inventor
George W Griesgraber
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Publication of BRPI0411916A publication Critical patent/BRPI0411916A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

"IMIDAZOQUINOLINAS SUBSTITUìDAS POR SULFONAMIDA". A presente invenção refere-se a compostos de imidazoquinolina e tetrahidroimidazoquinolina que contêm funcionalidade de sulfonamida na posição 1 são úteis como modificadores de resposta imune. Os compostos e composições da invenção podem induzir a biossíntese de várias citocinas e são úteis no tratamento de uma variedade de condições incluindo doenças virais e doenças neoplásicas."IMMEDAZOKININS SUBSTITUTED BY SULPHONAMIDE". The present invention relates to imidazoquinoline and tetrahydroimidazoquinoline compounds which contain sulfonamide functionality at position 1 and are useful as immune response modifiers. The compounds and compositions of the invention may induce biosynthesis of various cytokines and are useful in treating a variety of conditions including viral diseases and neoplastic diseases.

BRPI0411916-9A 2003-06-27 2004-06-25 sulfonamide-substituted imidazoquinolines BRPI0411916A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48320003P 2003-06-27 2003-06-27
PCT/US2004/020607 WO2005003065A2 (en) 2003-06-27 2004-06-25 Sulfonamide substituted imidazoquinolines

Publications (1)

Publication Number Publication Date
BRPI0411916A true BRPI0411916A (en) 2006-08-15

Family

ID=33563911

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0411916-9A BRPI0411916A (en) 2003-06-27 2004-06-25 sulfonamide-substituted imidazoquinolines

Country Status (16)

Country Link
EP (1) EP1638566A4 (en)
JP (1) JP2007521280A (en)
KR (1) KR20060035637A (en)
CN (1) CN1812789B (en)
AR (2) AR044922A1 (en)
AU (1) AU2004253929A1 (en)
BR (1) BRPI0411916A (en)
CA (1) CA2529322A1 (en)
IL (1) IL172427A0 (en)
MX (1) MXPA06000144A (en)
MY (1) MY157827A (en)
NZ (1) NZ544330A (en)
RU (1) RU2374246C2 (en)
TW (2) TW200511992A (en)
WO (2) WO2005003065A2 (en)
ZA (1) ZA200600769B (en)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265351A1 (en) 2003-04-10 2004-12-30 Miller Richard L. Methods and compositions for enhancing immune response
US7648997B2 (en) 2003-08-12 2010-01-19 Coley Pharmaceutical Group, Inc. Hydroxylamine substituted imidazoquinolines
JP5128815B2 (en) 2003-08-27 2013-01-23 スリーエム イノベイティブ プロパティズ カンパニー Aryloxy-substituted and arylalkyleneoxy-substituted imidazoquinolines
CA2537763A1 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for cd5+ b cell lymphoma
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
CA2540541C (en) 2003-10-03 2012-03-27 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
KR20060120069A (en) 2003-10-03 2006-11-24 쓰리엠 이노베이티브 프로퍼티즈 컴파니 Pyrazolopyridine and analogues thereof
WO2005048933A2 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
CN1906192A (en) 2003-11-14 2007-01-31 3M创新有限公司 Hydroxylamine substituted imidazo ring compounds
US8691837B2 (en) 2003-11-25 2014-04-08 3M Innovative Properties Company Substituted imidazo ring systems and methods
US8940755B2 (en) * 2003-12-02 2015-01-27 3M Innovative Properties Company Therapeutic combinations and methods including IRM compounds
JP2007517035A (en) 2003-12-29 2007-06-28 スリーエム イノベイティブ プロパティズ カンパニー Arylalkenyl and arylalkynyl substituted imidazoquinolines
AU2004312508A1 (en) 2003-12-30 2005-07-21 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
AU2005228150A1 (en) 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US8017779B2 (en) 2004-06-15 2011-09-13 3M Innovative Properties Company Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US8026366B2 (en) 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
US8541438B2 (en) 2004-06-18 2013-09-24 3M Innovative Properties Company Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
WO2006038923A2 (en) 2004-06-18 2006-04-13 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
US7915281B2 (en) 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
WO2006074003A2 (en) 2004-12-30 2006-07-13 3M Innovative Properties Company CHIRAL FUSED [1,2]IMIDAZO[4,5-c] RING COMPOUNDS
ZA200706251B (en) * 2004-12-30 2008-11-26 Coley Pharm Group Inc Immune response modifier formulations and methods
WO2006083440A2 (en) 2004-12-30 2006-08-10 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
CA2597092A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune reponse modifiers
US20080318998A1 (en) 2005-02-09 2008-12-25 Coley Pharmaceutical Group, Inc. Alkyloxy Substituted Thiazoloquinolines and Thiazolonaphthyridines
AU2006213746A1 (en) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted imidazo(4,5-c) ring compounds and methods
EP1869043A2 (en) 2005-04-01 2007-12-26 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
WO2006107851A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
ZA200803029B (en) * 2005-09-09 2009-02-25 Coley Pharm Group Inc Amide and carbamate derivatives of alkyl substituted /V-[4-(4-amino-1H-imidazo[4,5-c] quinolin-1-yl)butyl] methane-sulfonamides and methods
US8476292B2 (en) 2005-09-09 2013-07-02 3M Innovative Properties Company Amide and carbamate derivatives of N-{2-[4-amino-2-(ethoxymethyl)-1H-imidazo[4,5-c] quinolin-1-Yl]-1,1-dimethylethyl}methanesulfonamide and methods
EA014244B1 (en) * 2005-09-23 2010-10-29 Коли Фармасьютикал Груп, Инк. METHOD FOR1H-IMIDAZO[4,5-c]PYRIDINES AND ANALOGS THEREOF
EP3085373A1 (en) 2006-02-22 2016-10-26 3M Innovative Properties Company Immune response modifier conjugates
WO2008008432A2 (en) 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
SI2276486T1 (en) * 2008-03-24 2014-01-31 4Sc Discovery Gmbh Novel substituted imidazoquinolines
RS55819B1 (en) 2010-08-17 2017-08-31 3M Innovative Properties Co Lipidated immune response modifier compound compositions, formulations, and methods
CN103582496B (en) 2011-06-03 2016-05-11 3M创新有限公司 There is the Heterobifunctional connection base of polyethylene glycol segment and the immune response modifier conjugate of being made by it
CA2838023C (en) 2011-06-03 2019-08-13 3M Innovative Properties Company Hydrazino 1h-imidazoquinolin-4-amines and conjugates made therefrom
JP6487921B2 (en) 2013-12-17 2019-03-20 ファイザー・インク Novel 3,4-disubstituted-1H-pyrrolo [2,3-b] pyridines and 4,5-disubstituted-7H-pyrrolo [2,3-c] pyridazines as LRRK2 inhibitors
EP3350178B1 (en) * 2015-09-14 2021-10-20 Pfizer Inc. Novel imidazo [4,5-c]quinoline and imidazo [4,5-c][1,5]naphthyridine derivatives as lrrk2 inhibitors
JP7011764B2 (en) 2016-07-07 2022-01-27 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー Antibody adjuvant complex
MX2019010756A (en) 2017-03-10 2020-01-20 Pfizer Novel imidazo[4,5-c]quinoline derivatives as lrrk2 inhibitors.
CA3074611A1 (en) 2017-09-06 2019-03-14 BioNTech SE Substituted imidazoquinolines as agonists of tlr7
US11306083B2 (en) 2017-12-20 2022-04-19 3M Innovative Properties Company Amide substituted imidazo[4,5-C]quinoline compounds with a branched chain linking group for use as an immune response modifier
EP3937984A1 (en) 2019-03-15 2022-01-19 Bolt Biotherapeutics, Inc. Immunoconjugates targeting her2
JP2023507322A (en) * 2019-12-20 2023-02-22 ナミ セラピューティクス， インコーポレイテッド Formulated and/or co-formulated liposomal compositions containing Toll-like receptor ("TLR") agonist prodrugs useful in the treatment of cancer and methods thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH31245A (en) * 1991-10-30 1998-06-18 Janssen Pharmaceutica Nv 1,3-Dihydro-2H-imidazoÄ4,5-BÜ-quinolin-2-one derivatives.
EP0894797A4 (en) * 1997-01-09 2001-08-16 Terumo Corp Novel amide derivatives and intermediates for the synthesis thereof
IL124914A (en) * 1997-06-26 2000-10-31 Akzo Nobel Nv Pharmaceutical compositions containing 6-aryl-2,3,5,6-tetrahydroimidazo¬2,1-a¾isoquinoline derivatives and some new such compounds
JP2000119271A (en) * 1998-08-12 2000-04-25 Hokuriku Seiyaku Co Ltd 1H-imidazopyridine derivative
ES2340488T3 (en) * 1998-10-26 2010-06-04 The Research Foundation Of State University Of New York SALTS DERIVED FROM LIPOIC ACID AND ITS USE FOR THE TREATMENT OF DISEASES.
US6331539B1 (en) * 1999-06-10 2001-12-18 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines
EP1719511B1 (en) * 2001-11-16 2008-12-10 3M Innovative Properties Company N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide, a pharmaceutical composition comprising the same and use thereof
US6677349B1 (en) * 2001-12-21 2004-01-13 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines

Also Published As

Publication number Publication date
ZA200600769B (en) 2007-05-30
WO2005003064A3 (en) 2005-03-31
EP1638566A4 (en) 2009-03-25
KR20060035637A (en) 2006-04-26
WO2005003065A2 (en) 2005-01-13
EP1638566A2 (en) 2006-03-29
MXPA06000144A (en) 2006-04-07
WO2005003065A3 (en) 2005-03-10
RU2374246C2 (en) 2009-11-27
WO2005003064A2 (en) 2005-01-13
CN1812789B (en) 2010-07-14
TW200514784A (en) 2005-05-01
CN1812789A (en) 2006-08-02
NZ544330A (en) 2009-06-26
RU2005138915A (en) 2006-06-27
JP2007521280A (en) 2007-08-02
IL172427A0 (en) 2006-04-10
TW200511992A (en) 2005-04-01
MY157827A (en) 2016-07-29
AU2004253929A1 (en) 2005-01-13
CA2529322A1 (en) 2005-01-13
AR044923A1 (en) 2005-10-12
AR044922A1 (en) 2005-10-12

Similar Documents

Publication Publication Date Title
BRPI0411916A (en) sulfonamide-substituted imidazoquinolines
BR0116026A (en) Thioether-Replaced Imidazoquinolines
BR0011448A (en) Amide Substituted Imidazoquinolines
BR0214999A (en) Amide-substituted imidazopyridines
BR0214750A (en) Substituted thioether imidazoquinolines
CR8649A (en) FORMAMIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES
UY30274A1 (en) SUBSTITUTED DERIVATIVES OF THE N- (4-METHYL-1,3-TIAZOL-2-IL) GUANIDINE, PHARMACEUTICAL FORMULATIONS CONTAINING IT AND APPLICATIONS
BR0011433A (en) Imidazoquinolines substituted with sulfonamide and sulfamide
BR0316350A (en) Diaminotriazoles useful as protein kinase inhibitors
BR0116034A (en) Substituted imidazopyridines
BRPI0411528A (en) use of isomalt as prebiotic
DE60325379D1 (en) Composition containing 6-Ä3- (1-adamantyl) -4-methoxyphenyl-2-naphthanoic acid for the treatment of dermatological diseases
ECSP066701A (en) SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES
BR0014214A (en) Amide substituted imidazoquinolines
BR0305426A (en) Hsv ns5b polymerase inhibitor compounds as well as pharmaceutical composition comprising the same
CR10700A (en) SULFONAMIDE DERIVATIVES
BRPI0507085A (en) sulfonamide derivatives, pharmaceutical composition, uses, processes for preparation and combination
BRPI0410660A (en) 2-amino-pyridine derivatives as ß2 adrenoreceptor agonists
CR8636A (en) USEFUL COMPOUNDS FOR THE TREATMENT OF DISEASES
PA8603001A1 (en) USEFUL COMPOUNDS FOR THE TREATMENT OF DISEASES
BRPI0408848A (en) oral cladribine formulations
CY1111778T1 (en) THIOXANTHENIUM DERIVATIVES AS UNIQUE ANTI-COUNSELING AGENTS FOR USE IN TREATMENT OF POLLUTICAL DISEASES
BR0214694A (en) 1,3-diarylprop-2-en-1-ones, compositions containing them and use
CR10382A (en) 2-ALCOXI-3,4,5-TRIHIDROXI-ALQUILAMIDA-BENZAZEPINAS, ITS PREPARATION, COMPOSITIONS THAT CONTAIN AND USE
CR10390A (en) DERIVATIVES OF 2-ALCOXI-3,4,5-TRIHIDROXI-ALQUILAMIDA, ITS PREPARATION, COMPOSITIONS THAT CONTAIN THEM AND USE

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.